!!Tibor Harkany - Curriculum Vitae \\ __Education, academic degrees & docentship (“habilitation”):__ \\ *2005 Docent in Neuropharmacology (Dnr. 3664/2005), Karolinska Institutet, Stockholm, Sweden\\ *1999 PhD in Medical Sciences (summa cum laude). Semmelweis Medical School, Budapest, Hungary (No. 249)\\ *1995 M.Sc. (No. 291/1995), József Attila University, Szeged, Hungary \\ __Commission of trust:__ \\ *2016 Invited panellist for the H2020 call 'Health, Demographic Change and Wellbeing'\\ *2012, 2015 Panelist for the Life & Health Sciences 2015 Call of Fundação para a Ciência e a Tecnologia (FCT), Lisboa, Portugal.\\ *2015 Panelist for the Neuroscience Board, Hungarian National Research Council (OTKA), Budapest, Hungary.\\ *2014 Mid-term review committee member, Swammerdam Institue for Life Sciences (SILS), University of Amsterdam.\\ *2014- Peer review evaluator for Horizon2020 (advanced ERC grants and health call).\\ *2013 Review board member, “EU Joint Programme – Neurodegenerative Disease Research” (JPND).\\ *2012-2013 Peer review evaluator for FP7 “Ideas” work programme (advanced ERC grants).\\ *2012-2013 KID funding panel member of the Karolinska Institutet (2 funding cycles/year).\\ *2012 Reviewer, Karolinska Institutet-NIH Training Program in Neuroscience.\\ *2009-present Interviewer and evaluator, EMBO long-term and short-term fellowship (>20 grants), on-going.\\ *2008 Review board member of Era-Net NEURON/neurodegenerative diseases for the European Commission (2008).\\ \\ __Recent research grants:__ \\ *2015-2016 Novo Nordisk Foundation (Denmark), principal investigator\\ *2015-2016 Hjärnfonden (Swedish Brain Research Foundation), principal investigator\\ *2015 GW Pharmaceuticals, Histon/Cambridge, United Kingdom, principal investigator\\ *2014-2017 European Union 7th Framework programme, PAINCAGE integrated project, #603191, work package leader\\ *2014 Petrus & Augusta Hedlunds Foundation (Sweden; competitive renewal), co-principal investigator\\ *2014 Novo Nordisk Foundation (Denmark; competitive renewal), principal investigator\\ *2014-2018 Swedish Medical Research Council (Vetenskapsrådet), principal investigator\\ \\ __Organization:__ \\ \\ 2015 Gordon Research Conference “Cannabinoid Functions in the CNS”, chair (with M. Maccarrone), Il Ciocco Resort, Tuscany, Italy\\ \\ __Editorial boards:__ \\ *2006 Editorial board member, Current Signal Transduction Therapy, Bentham Scientific Publisher\\ *2008 Honorary editorial board member, International Journal of BioSciences and Technology\\ *2008 Scientific review associate, European Journal of Neuroscience\\ *2010 Review editor, Frontiers in Systems Biology\\ *2010 Review editor, Frontiers in Neurodegenerative Diseases\\ *2012 Editorial board member, Dataset Papers in Neuroscience\\ *2013 Editorial board member, Journal of Biochemistry & Biophysics\\ *2015 Field editor (Neuroscience), Amino Acids (Springer)\\ *2016 Editorial board member, Cannabis and Cannabinoid Research (Mary Ann Liebert Inc.)\\ *2016 Editorial board member/assoc. editor, Acta Neuropathologica Communications (Springer)\\ *2011 Guest editor: “Molecular mechanisms of neuronal specification” – European Journal of Neuroscience, Special Issue\\ *2014 Guest editor: “Neurotrophin-endocannabinoid interactions in pain” – European Journal of Neuroscience, Special Issue